SCHEMBL7121244

SCHEMBL7121244

CCOC(=O)/C(=C\NC1CCCCC1)C(=O)c1ccc(I)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ MAPT P10636 5/20 0.39
▸ GAA P10253 2/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ KDM4E B2RXH2 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ CASP3 P42574 2/20 0.36
▸ CNR1 P21554 3/20 0.35
▸ CNR2 P34972 3/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ DHODH Q02127 1/20 0.34
▸ LMNA P02545 2/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7121246 1.00 NPC1 (0.41) NPC1RAB9AMAPTGAAMEN1
SCHEMBL4958597 0.85 MAPT (0.44) NPC1RAB9AMAPTGAAMEN1
SCHEMBL4958601 0.85 MAPT (0.44) NPC1RAB9AMAPTGAAMEN1
SCHEMBL10375594 0.79 USP2 (0.46) NPC1RAB9AMAPTGAAMEN1
SCHEMBL7955352 0.77 CYP2C19 (0.47) NPC1RAB9AMAPTGAAKDM4E
SCHEMBL7955350 0.77 CYP2C19 (0.47) NPC1RAB9AMAPTGAAKDM4E
SCHEMBL5256942 0.77 GAA (0.48) NPC1RAB9AMAPTGAAMEN1
SCHEMBL10592860 0.77 GAA (0.48) NPC1RAB9AMAPTGAAMEN1
SCHEMBL9492350 0.77 GAA (0.48) NPC1RAB9AMAPTGAAMEN1
SCHEMBL7120280 0.76 MEN1 (0.38) MAPTGAAMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0793656-B1 NOVEL BENZYL PYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2003-03-26 — — EP disclosed
US-5763450-A BACTERICIDES; TREATMENT OF INFECTIOUS DISEASES HOFFMANN-LA ROCHE INC. (US) 1998-06-09 — — US disclosed
EP-0793656-A1 NOVEL BENZYL PYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 1997-09-10 — — EP disclosed
WO-1996016046-A2 NOVEL BENZYL PYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 1996-05-30 — — WO disclosed
Send feedback